Dosing considerations with amifostine: A review of the literature and clinical experience

Seminars in Oncology

Volumn 26, Issue 2 SUPPL. 7, 1999, Pages 108-119

  Dorr, R T ^a   Holmes, B C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE;

ALLERGIC REACTION; ARTICLE; CELL PROTECTION; CHILD; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECT; HUMAN; HYPOCALCEMIA; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; VOMITING;

AMIFOSTINE; CLINICAL TRIALS; CYTOPROTECTION; DRUG ADMINISTRATION SCHEDULE; HUMANS; PROTECTIVE AGENTS;

EID: 0033052625     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)